The addition of another large control group specifically consisting of patients with other viral pneumonia with comparable characteristics and disease severity would further have strengthened our understanding of the COVID-19 specificity of AT1R and ETAR auto-antibody levels. The gene discussed is AGTR1; the disease is viral pneumonia.